68 related articles for article (PubMed ID: 15828450)
1. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin.
Limtrakul P; Khantamat O; Pintha K
J Chemother; 2005 Feb; 17(1):86-95. PubMed ID: 15828450
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Comparative Analysis of the Effect and Structure-Based Influencing Factors of Flavonols on Lipid Accumulation.
Ang B; Yang T; Wang Z; Cheng Y; Chen Q; Wang Z; Zeng M; Chen J; He Z
J Agric Food Chem; 2024 Apr; 72(14):8237-8246. PubMed ID: 38530935
[TBL] [Abstract][Full Text] [Related]
3. Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin.
Borska S; Sopel M; Chmielewska M; Zabel M; Dziegiel P
Molecules; 2010 Feb; 15(2):857-70. PubMed ID: 20335952
[TBL] [Abstract][Full Text] [Related]
4. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
Choi JS; Piao YJ; Kang KW
Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726
[TBL] [Abstract][Full Text] [Related]
5. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.
Bansal T; Jaggi M; Khar RK; Talegaonkar S
J Pharm Pharm Sci; 2009; 12(1):46-78. PubMed ID: 19470292
[TBL] [Abstract][Full Text] [Related]
6. Effect of quercetin on P-glycoprotein transport ability in Chinese healthy subjects.
Wang SY; Duan KM; Li Y; Mei Y; Sheng H; Liu H; Mei X; Ouyang W; Zhou HH; Liu ZQ
Eur J Clin Nutr; 2013 Apr; 67(4):390-4. PubMed ID: 23422925
[TBL] [Abstract][Full Text] [Related]
7. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target.
Scambia G; Ranelletti FO; Panici PB; De Vincenzo R; Bonanno G; Ferrandina G; Piantelli M; Bussa S; Rumi C; Cianfriglia M
Cancer Chemother Pharmacol; 1994; 34(6):459-64. PubMed ID: 7923555
[TBL] [Abstract][Full Text] [Related]
8. CYP1A1 and CYP3A4 modulation by dietary flavonoids in human intestinal Caco-2 cells.
Sergent T; Dupont I; Van der Heiden E; Scippo ML; Pussemier L; Larondelle Y; Schneider YJ
Toxicol Lett; 2009 Dec; 191(2-3):216-22. PubMed ID: 19766177
[TBL] [Abstract][Full Text] [Related]
9. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes.
Hellum BH; Hu Z; Nilsen OG
Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):23-30. PubMed ID: 17214607
[TBL] [Abstract][Full Text] [Related]
10. Potential Targets and Mechanisms of Bitter Almond-Licorice for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking.
Hong Q; Shang X; Wu Y; Nie Z; He B
Curr Pharm Des; 2023; 29(33):2655-2667. PubMed ID: 38018195
[TBL] [Abstract][Full Text] [Related]
11. Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies.
Alkhalifa AE; Al-Ghraiybah NF; Odum J; Shunnarah JG; Austin N; Kaddoumi A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003477
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review.
Asnaashari S; Amjad E; Sokouti B
Cancer Cell Int; 2023 Sep; 23(1):211. PubMed ID: 37743502
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Strategies for Overcoming Multidrug Resistance to Chemotherapy.
Fedotcheva TA; Shimanovsky NL
Pharm Chem J; 2023; 56(10):1307-1313. PubMed ID: 36683825
[TBL] [Abstract][Full Text] [Related]
14. Why Do Dietary Flavonoids Have a Promising Effect as Enhancers of Anthracyclines? Hydroxyl Substituents, Bioavailability and Biological Activity.
Golonko A; Olichwier AJ; Swislocka R; Szczerbinski L; Lewandowski W
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613834
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways.
Qattan MY; Khan MI; Alharbi SH; Verma AK; Al-Saeed FA; Abduallah AM; Al Areefy AA
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557997
[TBL] [Abstract][Full Text] [Related]
16. Natural Blockers of PD-1/PD-L1 Interaction for the Immunotherapy of Triple-Negative Breast Cancer-Brain Metastasis.
Nakhjavani M; Shigdar S
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551742
[TBL] [Abstract][Full Text] [Related]
17. Modulation of p-glycoprotein-mediated efflux pirarubicin in living multidrug-resistant K562/Dox cell lines by 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid via impairment of the cellular energetic state.
Myint O; Wattanapongpitak S; Kothan S; Udomtanakunchai C; Tima S; Tungjai M
Toxicol Rep; 2022; 9():1443-1451. PubMed ID: 36518452
[TBL] [Abstract][Full Text] [Related]
18. Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets.
Asgharian P; Tazekand AP; Hosseini K; Forouhandeh H; Ghasemnejad T; Ranjbar M; Hasan M; Kumar M; Beirami SM; Tarhriz V; Soofiyani SR; Kozhamzharova L; Sharifi-Rad J; Calina D; Cho WC
Cancer Cell Int; 2022 Aug; 22(1):257. PubMed ID: 35971151
[TBL] [Abstract][Full Text] [Related]
19. The complex relationship between multiple drug resistance and the tumor pH gradient: a review.
Koltai T
Cancer Drug Resist; 2022; 5(2):277-303. PubMed ID: 35800371
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-Containing Extract Exerts Anti-Cancer Activity through Oral Administration in A549-Xenografted BALB/C Nude Mice: Synergistic Effect between Paclitaxel and Flavonoids or Lignoids.
Cai D; Jin J; Bi H; Zhong G; Zhou M; Guo J; Cai Y; Liang M; Gu Q; Hu Z; Lai Y; Dai Z; Li L; Chen Y; Gao H; Huang M
Evid Based Complement Alternat Med; 2022; 2022():3648175. PubMed ID: 35509628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
